“These products deliver proven value—every $1 spent on OTC medicines saves over $7 in healthcare costs, totaling $167 billion in annual savings through avoided doctor visits and lower-cost treatment options."
The FDA and HHS have announced plans to phase out petroleum-based synthetic dyes from the national food supply and replace them with natural ingredients.
The awards honor strategic innovation and marketing in OTC medicine, dietary supplements, and OTC medical devices.
“We look forward to working collaboratively with FDA and other stakeholders on this important scientific and regulatory paradigm shift,” says the CHPA.
“It cannot be emphasized enough how vital expanded access to OTC medicines is to public health, and the Rx-to-OTC switch process has delivered safe, effective, and affordable options for decades.”
The Senate confirmed Dr. Makary's nomination by a vote of 56-44.
Bradley is the president and CEO of Foundation Consumer Healthcare and has been a standing member of CHPA’s board of directors.
DeWolf, a transformative figure in the industry, received the award, the highest honor in the U.S. consumer healthcare sector, for decades of dedication and service.
The event program also included the announcement of the foundation’s new board member, Mark Pearson, Reckitt’s vice president of Marketing Health.
The proposed order challenges FDA’s longstanding recognition of PE as a safe and effective treatment for nasal congestion.
